Recombinant Human IL-20重组人白介素20

Description :
FAQ COA 已发表文献 IL-20 belongs to the IL-10 family. It is a cytokine structurally related to interleukin 10.Human IL-20 is synthesized as a 176 amino acid (aa)precursor with a 24 aa signal sequence and a 152aa mature segment. IL-20 production has been found in skin,trachea, and other tissues. In particular, it is produced by activated keratinocytes and monocytes.It has been shown that IL-20 transduces its signal through signal transducer and activator of transcription 3 (STAT3) in keratinocytes. It may be involved in epidermal function and psoriasis. It also regulates the proliferation and differentiation of keratinocytes during inflammation, particularly inflammation associated with the skin. Also, it is reported to induce the proliferation of multipotential hematopoietic progenitor cells, direct the differentiation and expansion of keratinocytes, and promote the release of proinflammatory mediators in keratinocytes and other IL-20 receptor expressing cells. Product Properties Synonyms Cytokine Zcyto10 Accession Q9NYY1 GeneID 50604 Source E.coli-derived Human IL-20, Leu25-Glu176, with an N-terminal Met. Molecular Weight Approximately 17.6kDa. AA Sequence MLKTLNLGSC VIATNLQEIR NGFSEIRGSV QAKDGNIDIR ILRRTESLQD TKPANRCCLL RHLLRLYLDR VFKNYQTPDH YTLRKISSLA NSFLTIKKDL RLCHAHMTCH CGEEAMKKYS QILSHFEKLE PQAAVVKALG ELDILLQWME ETE Tag None Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder. Purity > 95% by SDS-PAGE and HPLC analyses. Biological Activity The ED50as determined by a cell proliferation assay using human IL-20R and human IL-20R co-transfected murine BaF3 pro-B cells is less than 0.5 ng/mL, corresponding to a specific activity of > 2.0 106IU/mg.Fully biologically active when compared to standard. Endotoxin EUper 1g of the protein by the LAL method. Formulation Lyophilized from a 0.2 m filtered concentrated solution in PBS, pH 7.2, with trehalose. Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at -20C. Further dilutions should be made in appropriate buffered solutions.